Ovarian Hyperstimulation Syndrome
CRC Press (Verlag)
978-0-367-55110-0 (ISBN)
Offers a state-of-the-art overview of all clinical aspects of OHSS
Provides focused OHSS guidance for gynecologists, reproductive specialists and healthcare professionals
Highlights the role of modern ovarian stimulation protocols in reducing OHSS
George Lainas MD is a Reproductive Gynecologist at Eugonia Assisted Reproductive Unit, Athens, Greece, and Senior Deputy of the Special Interest Group in Reproductive Endocrinology of the European Society of Human Reproduction and Embryology. Dr Lainas is also a member of the Guideline Development Group of Ovarian Stimulation and also a member of the European Committee for the development of Key Performance Indicators (KPIs) in Ovarian Stimulation.His research work has made a significant contribution in the improvement of treatment protocols and prevention of severe complications in IVF; he is a regularly invited speaker at international scientific conferences and seminars and a reviewer in peer-reviewed scientific journals. Tryfon G Lainas MD, PhD, is Director of the Eugonia Assisted Reproductive Unit, Athens, Greece; the former head of the department of endoscopic surgery at 'IASO' maternity hospital, he also organized the 1st International Seminar of Perinatal Medicine on the biology of reproduction in 1992.
Part 1 Introduction: Definition 1.1 ART and OHSS Development (Early-Late) 1.2 Clinical Manifestations of Ovarian Hyperstimulation Syndrome 1.3 Epidemiology of OHSS 1.4 Complications of Ovarian Hyperstimulation Syndrome Part 2 Pathophysiology of OHSS 2.1 Pathophysiology of Ovarian Hyperstimulation Syndrome: The Role of Corpus Luteum and Vascular Permeability 2.2 Genetic Causes of OHSS Part 3 Classification of OHSS 3.1 Ovarian Hyperstimulation Syndrome: Historical Classification Systems 3.2 Modern OHSS Classification Systems Part 4 Prediction of OHSS 4.1 Risk Factors for OHSS 4.2 OHSS Prediction Part 5 Primary Prevention: OHSS Reduction Strategies 5.1 Types and Doses of Gonadotrophins and Alternative Strategies to Reduce OHSS Incidence 5.2 Coasting and hCG Dose Reduction 5.3 Gonadotropin-Releasing Hormone (GnRH) Antagonist Protocols 5.4 Embryo and Oocyte Cryopreservation 5.5 In Vitro Maturation – Navigating Success and Safety Part 6 Secondary Prevention: OHSS Elimination Strategies 6.1 GnRH Agonist Triggering and "Freeze-All" Strategy 6.2 Navigating through OHSS with GnRH Agonist Triggers and Low-Dose hCG for Luteal Support 6.3 OHSS Elimination: Alternative Agents for Final Oocyte Maturation Part 7 Tertiary Prevention: Outpatient Management 7.1 Luteal GnRH Antagonist Administration for Management of Established Severe OHSS 7.2 Dopamine Agonists 7.3 Glucocorticoids and OHSS Part 8 Management of Established OHSS 8.1 Management of Late OHSS 8.2 Criteria for Hospitalization and Inpatient Management
| Erscheinungsdatum | 01.11.2025 |
|---|---|
| Zusatzinfo | 13 Tables, black and white; 1 Line drawings, color; 4 Line drawings, black and white; 5 Halftones, color; 6 Illustrations, color; 4 Illustrations, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 178 x 254 mm |
| Gewicht | 560 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Histologie / Embryologie | |
| Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
| ISBN-10 | 0-367-55110-1 / 0367551101 |
| ISBN-13 | 978-0-367-55110-0 / 9780367551100 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
